Nurix Therapeutics (NRIX) Share-based Compensation (2019 - 2026)
Nurix Therapeutics' Share-based Compensation was $11.39 million in fiscal Q2 2026 (quarter ended May 31, 2026), up 9.7% from $10.39 million a year earlier and up 21.1% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Share-based Compensation (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nurix Therapeutics' Share-based Compensation was $39.65 million through May 31, 2026, up 9.0% year-over-year; for FY2025 (ended Nov 30, 2025), it was $37.97 million, up 11.9% from FY2024.
- Share-based Compensation has now increased for six consecutive fiscal years, with a five-year compound annual growth rate of 54.6% (FY2020 to FY2025).
- In earlier fiscal years, Share-based Compensation was $33.93 million in FY2024 (+0.8%), $33.67 million in FY2023 (+19.7%), $28.13 million in FY2022 (+78.0%) and $15.8 million in FY2021 (+267.4%).
- The fiscal Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to fiscal Q4 2019.
- Compared with a year earlier, Share-based Compensation has increased for nine straight quarters, with growth averaging 9.3% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q3 2021 (growth of 286.8%); the worst was fiscal Q1 2024 (a decline of 7.8%).
- Per Business Quant data, NRIX's Share-based Compensation in the three fiscal quarters before Q2 2026 was $9.4 million (Q1 2026), $9.09 million (Q4 2025) and $9.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Nurix Therapeutics | 2.45 Bn | 448.58 Mn | - | 11.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 11.39 Mn |
| Feb 28, 2026 | 9.40 Mn |
| Nov 30, 2025 | 9.09 Mn |
| Aug 31, 2025 | 9.77 Mn |
| May 31, 2025 | 10.39 Mn |
| Feb 28, 2025 | 8.72 Mn |
| Nov 30, 2024 | 8.51 Mn |
| Aug 31, 2024 | 8.75 Mn |
| May 31, 2024 | 8.85 Mn |
| Feb 29, 2024 | 7.82 Mn |
| Nov 30, 2023 | 8.02 Mn |
| Aug 31, 2023 | 8.45 Mn |
| May 31, 2023 | 8.72 Mn |
| Feb 28, 2023 | 8.48 Mn |
| Nov 30, 2022 | 8.30 Mn |
| Aug 31, 2022 | 6.99 Mn |
| May 31, 2022 | 6.78 Mn |
| Feb 28, 2022 | 6.07 Mn |
| Nov 30, 2021 | 4.84 Mn |
| Aug 31, 2021 | 4.31 Mn |
API Access
Nurix Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();